NCT06461910 2026-03-03
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06056804 2025-04-02
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Beijing Friendship Hospital
Phase 2 Active not recruiting
NCT02535988 2023-09-21
Abscopal Effect for Metastatic Colorectal Cancer
Zhejiang Provincial People's Hospital
Phase 2 Withdrawn
NCT06024356 2023-09-06
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Beijing Friendship Hospital
Unknown
NCT05086614 2021-10-21
Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer
Fudan University
Phase 3 Recruiting
NCT02545751 2017-11-28
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Unknown